Insights
Advocacy For 75/25 Blended Relief Increases Prospects
HME grassroots advocacy has been the driving force for advancing 75/25 blended rate provisions through Senate and House…
August 23 2024Medtrade 2025 – Get Inspired This February In Dallas
Next year’s edition of the Medtrade show will be February 18-20, 2025 and once again held at the…
August 23 2024ResMed Expands Board Of Directors
ResMed recently expanded the size of its board of directors to 11 and has elected Christopher DelOrefice to…
August 23 2024DOJ Pilot Program: Effect On DME
On Aug 1, 2024 the Criminal Division of the Department of Justice (DOJ) rolled out a new Corporate…
August 23 2024Rifton Returns To Medtrade
RIFTON, N.Y. – Rifton Equipment recently signed on for Medtrade 2025, scheduled for Feb. 18-20 at the Kay…
August 23 2024Phase One Of PA For Orthoses And Osteogenesis
CMS will begin Phase one of two of adding new items to the Prior Authorization program for Medicare…
August 16 2024Leverage New Impact Study
The survey findings reinforce the urgent need to make sure that Congress hears directly from every corner of the…
August 16 2024Biden Administration Negotiates For Lower Drug Prices
The Biden-Harris Administration reached an agreement for new, lower prices for 10 selected drugs.
August 16 2024U.S. Supreme Court: End Of Chevron Deference
The U.S. Supreme Court recently overruled the Chevron doctrine, a longstanding principle that granted federal agencies wide latitude…
August 15 2024